Clinical Trial

Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 16, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The presence of a damage to the central and / or peripheral nervous system resulting from diseases of a different nature (such as, Multiple Sclerosis, Parkinson's disease, dementia, head trauma, stroke, epilepsy or other neurological syndromes) is commonly cause of both physical than mental disability. The evaluation of certain domains may be more difficult so, specific assessment tools are necessary to analyze them.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-07-07; most recent amendment 2024-10-14.
Trial Details
NCT Number NCT05450237
Lead Sponsor Neuromed IRCCS
Conditions Multiple Sclerosis, Epilepsy, Parkinson Disease, Dementia, Stroke
Enrollment 500 participants
Start Date 2022-07-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-16